CIK 0001235912 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
CVRx, Inc.
Sign in to watch- Ticker
- CVRX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 7634162850
- Business address
- 9201 WEST BROADWAY AVENUE, SUITE 650, MINNEAPOLIS, MN, 55445
- Former names
- CVRX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-02 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Gift | −2,000 | 628 | ||
| 2023-07-31 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Option exercise | +3,750 | $5.14 | $19K | 3,750 |
| 2023-07-31 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Sale | −1,122 | $17.49 | $20K | 2,628 |
| 2023-07-31 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Option exercise · Stock Option (right to buy) | −3,750 | $5.14 | $19K | 80,806 |
| 2023-06-05 | Jain Mudit K. Director | Grant or award · Stock Option (right to buy) | +12,012 | 12,012 | ||
| 2023-06-05 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +12,012 | 12,012 | ||
| 2023-06-05 | Hykes Kevin Director | Grant or award · Stock Option (right to buy) | +12,012 | 12,012 | ||
| 2023-06-05 | SHADAN MARTHA Director | Grant or award · Stock Option (right to buy) | +12,012 | 12,012 | ||
| 2023-06-05 | Nielsen Kirk G. Director | Grant or award · Stock Option (right to buy) | +12,012 | 12,012 | ||
| 2023-06-05 | Behbahani Ali Director | Grant or award · Stock Option (right to buy) | −12,012 | 12,012 | ||
| 2023-05-16 | Palmer Craig E. SVP, U.S. SALES | Option exercise | +295 | $0.24 | $70 | 295 |
| 2023-05-16 | Palmer Craig E. SVP, U.S. SALES | Option exercise · Stock Option (right to buy) | −295 | 0 | ||
| 2023-01-18 | Galle Liz VP OF GLOBAL CLINICAL RESEARCH | Grant or award · Stock Option (right to buy) | +26,000 | 26,000 | ||
| 2023-01-18 | Palmer Craig E. SVP, U.S. SALES | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-18 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2023-01-18 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2023-01-18 | Yared Nadim CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-01-11 | Yared Nadim CHIEF EXECUTIVE OFFICER | Gift | −7,080 | 20,255 | ||
| 2022-12-21 | Hykes Kevin Director | Grant or award · Stock Option (right to buy) | +5,246 | 5,246 | ||
| 2022-12-21 | Hykes Kevin Director | Grant or award · Stock Option (right to buy) | +21,776 | 21,776 |
Page 10 of 22 · 422 trades